Table 3 Change in SF-36 norm based Domain scores in responders among refractory HCV patients re-treated with pegylated interferon alpha 2b and ribavirin
SF-36 domain | Change in QOL scores compared to baseline At | 48 wks to 24 wks (24 wk-48 wk) | ||
|---|---|---|---|---|
24 wks | 48 wks | 72 wks | ||
Physical Function | -5.25* | -2.02 | 1.04 | 3.23 |
Role Physical | -7.02 | -4.87 | 5.15 | 2.14 |
Bodily Pain | -3.31 | -2.13 | 1.96 | 1.18 |
General Health | -4.53* | -3.88 | 1.55 | 0.65 |
Vitality | -8.28** | -8.40^ | 5.69 | -0.12 |
Social Functioning | -7.33 | -5.30 | 4.87 | 2.03 |
Role-Emotional | -4.98 | -2.42 | 5.50 | 2.56 |
Mental Health | -4.32 | -3.76 | 0.10 | 0.56 |
Physical Component Score | -5.99^^ | -3.54 | 2.26 | 2.45 |
Mental Component Score | -5.20* | -3.48 | 2.49 | 1.71 |